US Patent 8932607 Batches of recombinant adenovirus with altered terminal ends
Patent 8932607 was granted and assigned to Crucell on January, 2015 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8932607 Batches of recombinant adenovirus with altered terminal ends
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
